Albany Molecular Research ($AMRI) has announced plans to close a facility in Budapest, axing 100 jobs in the process. The contract research group and manufacturer says it plans to complete a restructuring in the second quarter. Story
| Sponsored by: Catalent | Published: April 29, 2013
In order to accelerate the production of biological molecules, companies have been exploring disposable, single-use systems. Download this ebook to learn the impact and future use of single-use technologies, cost-saving opportunities, and challenges of implementing new drug development processes.